Increased serum IL-19 levels have been observed in various kidney diseases, including in various kidney diseases, including hydronephrosis accompanied by ureteral stones, diabetes, and polycystic kidney disease, as well as in kidney transplant recipients (Table 2). This evidence concerns the gene IL19 and diabetes mellitus.